Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy
Journal of the American College of Cardiology
Open Access Publication
Rights and Permissions
Ho CY, Mealiffe ME, Bach RG, Bhattacharya M, Choudhury L, Edelberg JM, Hegde SM, Jacoby D, Lakdawala NK, Lester SJ, Ma Y, Marian AJ, Nagueh SF, Owens A, Rader F, Saberi S, Sehnert AJ, Sherrid MV, Solomon SD, Wang A, Wever-Pinzon O, Wong TC, Heitner SB. Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2020 Jun 2;75(21):2649-2660. doi: 10.1016/j.jacc.2020.03.064. © 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Ho, Carolyn Y; Bach, Richard G; and et al., "Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy." Journal of the American College of Cardiology. 75, 21. 2649 - 2660. (2020).
ICTS (Institute of Clinical and Translational Sciences)
Supplemental material is available for this article at publisher site.